Peter Y. Kim
Actor

Peter Y. Kim Net Worth

1 year from now

Peter Y. Kim is an actor born on April 01, 1958. He has a MFA from the Yale School of Drama and made his Off-Broadway debut in Yoko Ono's rock opera, "New York Rock". He has appeared in numerous TV shows, films and commercials, including "Hackers" opposite Angelina Jolie. He is a founding member of Mr. Miyagi's Theatre Company and co-creator of their Off-Broadway comedy, "Sides: The Fear is Real...". He is also the Associate Producer of OBIE award winning NAATCO (National Asian American Theatre Company), teaches at Princeton University's Program in Theater and is the recipient of the Lilah Kan Red Socks Award.
Peter Y. Kim is a member of Actor

Age, Biography and Wiki

Who is it? Actor
Birth Day April 01, 1958
Birth Place American
Age 65 YEARS OLD
Alma mater Stanford University, Cornell University
Known for Discovering how proteins cause cell membranes to fuse, and pioneering efforts to develop an HIV vaccine based on inhibiting membrane fusion.
Institutions Merck & Co., Inc.
Website Peter S. Kim Lab at Stanford

💰 Net worth

Peter Y. Kim, a prominent actor based in America, is expected to have a net worth ranging from $100,000 to $1 million in the year 2024. Known for his exceptional talent and versatile acting skills, Peter Y. Kim has made a significant impact in the entertainment industry. With numerous notable roles in both film and television, he has gained a loyal fanbase and critical acclaim. As he continues to establish himself as a prominent figure in the acting world, Peter Y. Kim's net worth is projected to grow substantially in the coming years.

Biography/Timeline

1974

Kim is of Korean descent. Kim grew up in Ridgewood, New Jersey the son of a single mother, and his first job was in 1974 at a Roy Rogers restaurant, where he earned money to pay for college. Kim earned his A.B. in chemistry at Cornell University in 1979 and trained as a Ph.D. in Biochemistry at Stanford University under the guidance of Robert Baldwin. While at Stanford, he was also a Medical Scientist Training Program Fellow.

2001

Kim joined Merck in 2001 as executive vice President, Research and Development. He was promoted to President in January 2003. In this role Kim oversaw all of Merck's drug and vaccine research and development activities.

2013

During his tenure, Merck gained approval of more than 20 new medicines and vaccines. These include Januvia (the first DPP-4 inhibitor for type 2 diabetes), Gardasil (the first vaccine for prevention of cervical cancer), Isentress (the first HIV integrase inhibitor), Zostavax (the first vaccine for the prevention of shingles in adults), Rotateq (an oral vaccine for the prevention of rotavirus infection in infants), and Victrelis (the first hepatitis C protease inhibitor). In 2013, he retired from Merck and was succeeded by Roger Perlmutter

Some Peter Y. Kim images

Tags 1958 births American health care businesspeople American people of Korean descent Businesspeople in the pharmaceutical industry Cornell University alumni Fellows of the American Academy of Arts and Sciences Howard Hughes Medical Investigators Living people Massachusetts Institute of Technology faculty Members of the United States National Academy of Sciences Merck People from Ridgewood, New Jersey Recipients of the Ho-Am Prize in Science Stanford Medical School alumni American biochemists

You may also like

About the author

Lisa Scholfield

As a Senior Writer at Famous Net Worth, I spearhead an exceptional team dedicated to uncovering and sharing the stories of pioneering individuals. My passion for unearthing untold narratives drives me to delve deep into the essence of each subject, bringing forth a unique blend of factual accuracy and narrative allure. In orchestrating the editorial workflow, I am deeply involved in every step—from initial research to the final touches of publishing, ensuring each biography not only informs but also engages and inspires our readership.